Literature DB >> 8510609

Home cage behavior and lead treatment in rhesus monkeys: a comparison with open-field behavior.

S A Ferguson1, R O Medina, R E Bowman.   

Abstract

Nursery-reared rhesus monkeys were treated with no (n = 4) or moderate levels of lead (n = 4) during the first postnatal year. Mean blood lead levels peaked at 55 micrograms/dl at 5 weeks of age, averaged 36 micrograms/dl for the remainder of the first year postpartum, and declined to < or = 5 micrograms/dl for the 4 monkeys by 2.3 years of age. Previously, the lead-treated monkeys exhibited increased environmental exploration and decreased inactivity in a nonhuman primate version of the open field when tested at 4, 5, and 6 years of age (5,6). The current study was designed to assess behavior in the home cage of these monkeys at 6 years of age to determine: (a) whether the increased exploration was specific to the open field, and (b) any lead-related behavioral alterations specific to the home cage. Each monkey was observed twice weekly for 10 weeks and the duration and frequency of 17 behaviors were recorded. Lead treatment did not result in significant alterations in any of the six behaviors which occurred with enough frequency to warrant analysis. As a whole, all monkeys were either inactive or engaged in self-grooming for a large proportion of the test session. Less frequent were behaviors such as locomotion, environmental exploration, and self-directed behaviors. The distribution of behavioral activities in the home cage differed from that in the open field. Potential reasons for the expression of significant lead-related effects in the open field and not in the home cage are discussed as well as the differences in distribution of behavioral activities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510609     DOI: 10.1016/0892-0362(93)90073-w

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  3 in total

1.  Pharmacokinetics and behavioral effects of liposomal hydromorphone suitable for perioperative use in rhesus macaques.

Authors:  Lisa Krugner-Higby; Butch KuKanich; Brynn Schmidt; Timothy D Heath; Carolyn Brown
Journal:  Psychopharmacology (Berl)       Date:  2011-03-15       Impact factor: 4.530

2.  Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques.

Authors:  Lisa Krugner-Higby; Butch KuKanich; Brynn Schmidt; Timothy D Heath; Carolyn Brown; Lesley J Smith
Journal:  J Pharmacol Exp Ther       Date:  2009-04-07       Impact factor: 4.030

3.  Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis).

Authors:  Elizabeth A Nunamaker; Lisa C Halliday; David E Moody; Wenfang B Fang; Matthew Lindeblad; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.